SCHEMBL2959461

SCHEMBL2959461

CCCCCCCCC(CCCCCCCC)C(=O)NCCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.50
GNAI3 P08754 1/20 0.49
GNAO1 P09471 1/20 0.49
GNAI1 P63096 1/20 0.49
RRM1 P23921 1/20 0.47
DPP7 Q9UHL4 2/20 0.47
CA2 P00918 1/20 0.47
USP2 O75604 3/20 0.46
NAAA Q02083 1/20 0.46
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
TSHR P16473 1/20 0.45
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
FAAH O00519 2/20 0.45
SIRT6 Q8N6T7 1/20 0.44
SIRT1 Q96EB6 1/20 0.44
BIRC2 Q13490 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2961362 1.00 CNR1 (0.50) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL1882497 1.00 CNR1 (0.50) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL24688329 1.00 CNR1 (0.50) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL25748452 1.00 CNR1 (0.50) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL20942656 0.93 USP2 (0.55) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL8109755 0.91 USP2 (0.48) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL8108816 0.91 USP2 (0.48) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL8109149 0.91 USP2 (0.48) CNR1GNAI3GNAO1GNAI1RRM1
SCHEMBL8108620 0.91 TSHR (0.48) GNAI3GNAO1GNAI1RRM1DPP7
SCHEMBL6524995 0.91 CA2 (0.46) CNR1GNAI3GNAO1GNAI1RRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150265506-A1 Foam-Promoting Compounds CRODA UNIQEMA, INC. 2015-09-24 US disclosed
US-7754674-B2 Solvated non-ionic surfactants and fatty acids CRODA AMERICAS LLC (US) 2010-07-13 US disclosed
US-20100080767-A1 COMPOUNDS CRODA UNIQEMA, INC. (US) 2010-04-01 US disclosed
EP-2082022-A1 COMPOUNDS Croda Uniqema Inc (US) 2009-07-29 EP disclosed
EP-1643962-B1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS CRODA UNIQEMA INC (US) 2009-05-13 EP disclosed
US-20090105106-A1 Solvated non-ionic surfactants and fatty acids CRODA UNIQUEMA, INC. (US) 2009-04-23 US disclosed
WO-2008063501-A1 COMPOUNDS CRODA UNIQEMA, INC. (US) 2008-05-29 WO disclosed
EP-1643962-A1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS ICI Americas, Inc. (US) 2006-04-12 EP disclosed
WO-2005046654-A1 ANTIPHLOGISTIC AND ANALGESIC PLASTER COMPRISING PIROXICAM COMPOUND ICURE (KR) 2005-05-26 WO disclosed
US-20050053681-A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds ICI AMERICAS, INC. (US) 2005-03-10 US disclosed
US-20050026805-A1 Solvated nonionic surfactants and fatty acids ICI AMERICAS, INC. (US) 2005-02-03 US disclosed
WO-2005007242-A1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS ICI AMERICAS, INC. (US) 2005-01-27 WO disclosed
US-20050014671-A1 Solvated nonionic surfactants and fatty acids ICI AMERICAS INC. 2005-01-20 US disclosed
EP-1392116-A1 SOLUTIONS OF ALKOXYLATED ALKANOL AMIDE SURFACTANTS AND ANTIMICROBIAL COMPOUNDS ICI Americas Inc. (US) 2004-03-03 EP disclosed
US-20030091667-A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds ICI UNIQEMA, INC. 2003-05-15 US disclosed
WO-2002098222-A1 SOLUTIONS OF ALKOXYLATED ALKANOL AMIDE SURFACTANTS AND ANTIMICROBIAL COMPOUNDS ICI AMERICAS INC. (US) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030091667-A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds AP3S1, SMURF1, CUTA CNR1 367/4885GNAI3 2978/4885GNAO1 2937/4885
US-20150265506-A1 Foam-Promoting Compounds SREBF1, SREBF2, EBP CNR1 420/4885GNAI3 4065/4885GNAO1 2644/4885
US-20100080767-A1 COMPOUNDS SREBF1, SGMS1, EBP CNR1 175/4885GNAI3 3988/4885GNAO1 2586/4885
US-20050053681-A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds CUTA, SMURF1, H1-0 CNR1 627/4885GNAI3 3586/4885GNAO1 3070/4885
US-20050026805-A1 Solvated nonionic surfactants and fatty acids LIPC, PAOX, FASN CNR1 759/4885GNAI3 2634/4885GNAO1 777/4885
US-20090105106-A1 Solvated non-ionic surfactants and fatty acids PAOX, FFAR3, ELOVL3 CNR1 871/4885GNAI3 2706/4885GNAO1 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.